Despite decades of global tobacco control efforts, Asia continues to carry a disproportionate share of the world’s smoking burden. According to the World Health Organization, there are approximately 1.3 billion tobacco users worldwide, with a significant majority living in Asian countries. China alone accounts for more than 300 million smokers, the largest national smoking population globally. In South-East Asia, male smoking prevalence remains among the highest in the world, with countries such as Indonesia reporting rates exceeding 65 percent among adult men.

The scale of tobacco use translates into substantial health consequences. Data from the Global Burden of Disease study consistently identify smoking as a leading risk factor for cancer, cardiovascular disease and chronic respiratory illness across the region. Cardiovascular conditions in particular account for a large share of tobacco-attributable deaths. For many Asian health systems already under strain, tobacco-related disease represents a persistent and preventable burden.

In Pakistan, the challenge reflects broader regional trends. WHO estimates suggest that more than 18 million adults use tobacco, while exposure to secondhand smoke remains widespread. Survey data indicate that over one-third of adults are regularly exposed to passive smoke, compounding long-term cardiovascular and respiratory risks.

Yet the trajectory is not uniformly stagnant. Since 2000, several Asian countries have recorded gradual declines in smoking prevalence. Japan, for instance, has reduced adult smoking rates from above 30 percent in the late 1990s to below 15 percent today, following sustained taxation, regulatory reform and public education campaigns. China has also seen modest declines in recent years, although its vast population means the absolute number of smokers remains high. In contrast, progress in parts of South-East Asia has been slower, particularly where enforcement and cessation support remain limited.

A critical distinction emerges when examining these trends. While prevalence percentages have declined in some countries, population growth often offsets these gains, leaving the total number of smokers relatively large. As a result, the health burden does not fall as quickly as percentages alone might suggest.

Public health measures have played a central role in reducing smoking rates. Higher excise taxes, graphic warning labels, smoke-free public spaces and sustained awareness campaigns are widely recognised as effective tools. However, enforcement gaps and illicit cigarette trade continue to undermine progress in several markets. The World Health Organization (WHO) has repeatedly noted that illicit tobacco weakens both fiscal and health objectives by maintaining affordability and accessibility outside regulatory frameworks.

Beyond enforcement challenges lies a behavioural reality. Nicotine, the addictive component of tobacco, makes quitting difficult for many long-term smokers. Scientific consensus distinguishes between nicotine and combustion. Nicotine drives dependence and is not risk-free, but the primary causes of smoking-related disease stem from the toxic chemicals produced when tobacco is burned.

Combustion generates thousands of harmful compounds, many of which are directly linked to cancer and cardiovascular damage. This distinction has been acknowledged by regulators such as the U.S. Food and Drug Administration, which emphasises that smoke from burning tobacco is responsible for the vast majority of tobacco-related illness.

This has prompted debate in several Asian countries about whether traditional restriction-based approaches are sufficient on their own. While taxation and bans remain central pillars of tobacco control, policymakers increasingly face the question of how to address smokers who struggle to quit despite repeated attempts. Some experts argue that strategies focused on reducing exposure to combustible smoke could complement existing measures, provided they are tightly regulated and accompanied by strong youth protections. Others caution against unintended consequences such as dual use or uptake among non-smokers.

Asia’s experience over the past two decades demonstrates that smoking prevalence can decline with sustained policy commitment. The remaining challenge is translating percentage reductions into meaningful decreases in disease burden. For countries across the region, the path forward will require balancing enforcement, behavioural understanding and science-driven policymaking. The scale of Asia’s smoking population means that even modest progress can yield substantial public health gains — but only if policies evolve in response to evidence rather than assumption.